Pharmacologic P2X purinergic receptor antagonism in the treatment of collagen-induced arthritis

Arthritis and Rheumatism

Volumn 63, Issue 11, 2011, Pages 3323-3332

  Ardissone, Vittoria ^a,b,h   Radaelli, Enrico ^c   Zaratin, Paola ^d   Ardizzone, Michele ^a   Ladel, Christoph ^d   Gattorno, Marco ^b,g   Martini, Alberto ^e   Grassi, Fabio ^f   Traggiai, Elisabetta ^e,g  

^a Istituto di Ricerche Biomediche Antoine Marxer SpA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d MERCK SERONO S A   (Switzerland)

^e UNIVERSITY OF GENOA   (Italy)

^f INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

^g NOVARTIS PHARMA AG   (Switzerland)

^h Procelltech   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; AUTOANTIBODY; COLLAGEN TYPE 2; PERIODATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTHRITIS; ARTICLE; CARTILAGE DEGENERATION; CD3+ T LYMPHOCYTE; CELL INFILTRATION; COLLAGEN INDUCED ARTHRITIS; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; HISTOPATHOLOGY; IMMUNE RESPONSE; LYMPH NODE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ADENOSINE TRIPHOSPHATE; ANIMALS; ARTHRITIS, EXPERIMENTAL; AUTOANTIBODIES; COLLAGEN TYPE II; LYMPH NODES; MALE; MICE; PURINERGIC P2X RECEPTOR ANTAGONISTS; T-LYMPHOCYTES, REGULATORY;

EID: 80155127855     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30556     Document Type: Article

References (20)

1. Asquit DL, Miller AM, McInnes IB, Liew FY,. Autoimmune disease: rheumatoid arthritis. Animal models of rheumatoid arthritis. Eur J Immunol 2009; 39: 2040-4.
2. Humby F, Bombardieri M, Manzo A, Kelly S, Blades MC, Kirkham B, et al. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med 2009; 6: e1.
3. Holmdahl R, Klareskog L, Rubin K, Larsson E, Wigzell H,. T lymphocytes in collagen II-induced arthritis in mice: characterization of arthritogenic collagen II-specific T-cell lines and clones. Scand J Immunol 1985; 22: 295-306. (Pubitemid 16228496)
4. Watson WC, Brown PS, Pitcock JA, Townes AS,. Passive transfer studies with type II collagen antibody in B10.D2/old and new line and C57Bl/6 normal and beige (Chediak-Higashi) strains: evidence of important roles for C5 and multiple inflammatory cell types in the development of erosive arthritis. Arthritis Rheum 1987; 30: 460-5. (Pubitemid 17080787)
5. + regulatory T cells in autoimmune arthritis. Immunol Rev 2010; 233: 97-111.
6. Nguyen LT, Jacobs J, Mathis D, Benoist C,. Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum 2007; 56: 509-20.
7. Drexler SK, Foxwell BM,. The role of Toll-like receptors in chronic inflammation. Int J Biochem Cell Biol 2010; 42: 506-18.
8. Labasi JM, Petrushova N, Donovan C, McCurdy S, Lira P, Payette MM, et al. Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J Immunol 2002; 168: 6436-45. (Pubitemid 34620068)
9. Schenk U, Westendorf AM, Radaelli E, Casati A, Ferro M, Fumagalli M, et al. Purinergic control of T-cell activation by ATP released through pannexin-1 hemichannels. Sci Signal 2008; 1: ra6.
10. Yip L, Woehrle T, Corriden R, Hirsh M, Chen Y, Inoue Y, et al. Autocrine regulation of T-cell activation by ATP release and P2X7 receptors. FASEB J 2009; 23: 1685-93.
11. Schenk U, Frascoli M, Proietti M, Geffers R, Traggiai E, Buer J, et al. ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors. Sci Signal 2011; 4: ra12.
12. Camps M, Ruckle T, Ji H, Ardissone V, Rintelen F, Shaw J, et al. Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 2005; 11: 936-43. (Pubitemid 41294438)
13. Traggiai E, Casati A, Frascoli M, Porcellini S, Ponzoni M, Sanvito F, et al. Selective preservation of bone marrow mature recirculating but not marginal zone B-cells in murine models of chronic inflammation. PLoS One 2010; 5: e11262.
14. Luross JA, Williams NA,. The genetic and immunopathological processes underlying collagen-induced arthritis. Immunology 2001; 103: 407-16. (Pubitemid 32744386)
15. Lampropoulou V, Hoehlig K, Roch T, Neves P, Calderon Gomez E, Sweenie CH, et al. TLR-activated B cells suppress T cell-mediated autoimmunity. J Immunol 2008; 180: 4763-73.
16. Caporali F, Capecchi PL, Gamberucci A, Lazzerini PE, Pompella G, Natale M, et al. Human rheumatoid synoviocytes express functional P2X7 receptors. J Mol Med 2008; 86: 937-49.
17. Ueda Y, Kondo M, Kelsoe G,. Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J Exp Med 2005; 201: 1771-80. (Pubitemid 41002896)
18. Lee DH, Park KS, Kong ID, Kim JW, Han BG,. Expression of P2 receptors in human B-cells and Epstein-Barr virus-transformed lymphoblastoid cell lines. BMC Immunol 2006; 7: 22.
19. Svensson L, Jirholt J, Holmdahl R, Jansson L,. B-cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin Exp Immunol 1998; 111: 521-6. (Pubitemid 28160894)
20. Edwards JC, Cambridge G,. B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nature Rev 2006; 6: 394-403.